Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02848846
Other study ID # FP7- ICT-2013.9.6
Secondary ID
Status Recruiting
Phase N/A
First received June 23, 2016
Last updated July 28, 2016
Start date June 2016
Est. completion date December 2018

Study information

Verified date July 2016
Source Catholic University of the Sacred Heart
Contact Paolo Maria M Rossini, Professor
Phone 00390635504435
Email paolomaria.rossini@policlinicogemelli.it
Is FDA regulated No
Health authority Italy: talian Ministry of Heath
Study type Interventional

Clinical Trial Summary

The NEBIAS ("NEurocontrolled BIdirectional Artificial upper limb and hand prosthesiS") proposal aims at developing and clinically evaluating (in selected amputees) a neuro-controlled upper limb prosthesis intuitively controlled and felt by the amputee as the natural one. This will be possible by means of a novel neural interface able to provide a stable and very selective connection with the nervous system. This goal will be achieved by combining microtechnology and material science and will allow, on one side, recording of the motor-related signals governing the actions of the amputated hand/arm for the motion control of a mechanical prosthesis, and on the other providing sensory feedback from tactile and kinesthetic sensors through neuromorphic stimulation of the adequate afferent pathway within the residual limb. The NEBIAS proposal is also aimed at finding out the 'language' intrinsically linking central nervous system with peripheral nerve signals in order to govern simple and complex hand/fingers movements. To reach this goal, a variety of techniques exploring brain and nerve functions will be assembled and integrated; this includes the analysis of electromagnetic brain and nerve signals, as well as of movement-related changes in brain's blood flow/metabolism.


Recruitment information / eligibility

Status Recruiting
Enrollment 2
Est. completion date December 2018
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult man or woman >18 yrs and < 71 yrs.

- Transradial amputation or Congenital Hand Hypoplasia

- Amputation in the chronic stable phase

- Good functionality of muscles of the stump

- Absence of severe stump pain (VAS<3)

Exclusion Criteria:

- Cognitive impairment

- Current or prior psychological impairments: Major personality disturbance (i.e. borderline, antisocial), Major depression, Bipolar I

- Pregnancy

- History of or active substance abuse disorder

- Acquired brain injury with residual impairment

- Intellectual Disability (IQ < 70)

- Prior neurological or musculo-skeletal disease

- Current or prior dermatological conditions

- Excessive sensitivity to electrical stimulation (people afraid of electrical stimulation or pain)

- Persons with other diseases that may affect the function of the nervous system. (Diabetes, HIV, Renal Failure)

- Persons with pacemakers

- People affected by autoimmune and chronic infective diseases in treatment with immunosuppressive drugs

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Device:
Robotic Hand
The patients will use the robotic hand for a period of one year that will be divided in 3 different phases. The first phase is the intensive phase where the patient will use the robotic hand from Monday to Friday all days. This phase will last 6 weeks. The second phase is the semi-intensive where the patient will use the robotic hand only two days per week. This phase will last 6 weeks. The third phase is the monitoring where the patient will use the robotic hand only one day per week until the end of the trial. During this phases the patient will perform different task requiring the use of the robotic hand.

Locations

Country Name City State
Italy Fondazione Policlinico Agostino Gemelli Roma Lazio

Sponsors (1)

Lead Sponsor Collaborator
Paolo Maria Rossini

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary performance of the robotic hand Different level of pressure (percentage of success); 1 year No
Primary performance of the robotic hand Virtual egg test (percentage of success); 1 year No
Primary performance of the robotic hand Pick and Lift (percentage of success); 1 year No
Primary performance of the robotic hand Texture recognition (percentage of success); 1 year No
Primary performance of the robotic hand Shape recognition (percentage of success); 1 year No
Primary performance of the robotic hand Compliance recognition (percentage of success) 1 year No
Secondary Cortical map changes Primary motor area (change of dimension and shape); 1 year No
Secondary Cortical map changes Primary somatosensory area (change of dimension and shape); 1 year No